These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33447334)

  • 1. Research as a pillar of Lassa fever emergency response: lessons from Nigeria.
    Olayinka AT; Nwafor CD; Akano A; Jan K; Ebhodaghe B; Elimian K; Ochu C; Okwor T; Ipadeola O; Ukponu W; Okudo I; Peter C; Ilori E; Ihekweazu C
    Pan Afr Med J; 2020; 37():179. PubMed ID: 33447334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing "One Health" community surveillance and emergency response practice.
    Tambo E; Adetunde OT; Olalubi OA
    Infect Dis Poverty; 2018 Apr; 7(1):37. PubMed ID: 29703243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.
    Dan-Nwafor CC; Furuse Y; Ilori EA; Ipadeola O; Akabike KO; Ahumibe A; Ukponu W; Bakare L; Okwor TJ; Joseph G; Mba NG; Akano A; Olayinka AT; Okoli I; Okea RA; Makava F; Ugbogulu N; Oladele S; Namara G; Muwanguzi EN; Naidoo D; Mutbam SK; Okudo I; Woldetsadik SF; Lasuba CL; Ihekweazu C
    Euro Surveill; 2019 May; 24(20):. PubMed ID: 31115314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).
    Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN
    Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the COVID-19 pandemic masking the deadlier Lassa fever epidemic in Nigeria?
    Reuben RC; Danladi MMA; Pennap GR
    J Clin Virol; 2020 Jul; 128():104434. PubMed ID: 32434707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cluster of nosocomial Lassa fever cases in a tertiary health facility in Nigeria: Description and lessons learned, 2018.
    Dan-Nwafor CC; Ipadeola O; Smout E; Ilori E; Adeyemo A; Umeokonkwo C; Nwidi D; Nwachukwu W; Ukponu W; Omabe E; Anaebonam U; Igwenyi N; Igbodo G; Eteng W; Uzoma I; Saleh M; Agboeze J; Mutbam S; de Gooyer T; Short R; Aniaku E; Onoh R; Ogah E; Nguku P; Oladejo J; Peter C; Ojo O; Ihekweazu C
    Int J Infect Dis; 2019 Jun; 83():88-94. PubMed ID: 30930184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
    Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of Lassa fever, its prevention and control practices and their predictors among healthcare workers during an outbreak in Northern Nigeria: A multi-centre cross-sectional assessment.
    Wada YH; Ogunyinka IA; Yusuff KB; Ochu CL; Yahaya M; Khalid GM; Mutalub YB; Adeniye SB
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010259. PubMed ID: 35286303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecological correlates and predictors of Lassa fever incidence in Ondo State, Nigeria 2017-2021: an emerging urban trend.
    Cadmus S; Taiwo OJ; Akinseye V; Cadmus E; Famokun G; Fagbemi S; Ansumana R; Omoluabi A; Ayinmode A; Oluwayelu D; Odemuyiwa S; Tomori O
    Sci Rep; 2023 Nov; 13(1):20855. PubMed ID: 38012226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale Lassa fever outbreaks in Nigeria: quantifying the association between disease reproduction number and local rainfall.
    Zhao S; Musa SS; Fu H; He D; Qin J
    Epidemiol Infect; 2020 Jan; 148():e4. PubMed ID: 31918780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in Lassa Fever Cases in Nigeria, January-March 2018.
    Ilori EA; Frank C; Dan-Nwafor CC; Ipadeola O; Krings A; Ukponu W; Womi-Eteng OE; Adeyemo A; Mutbam SK; Musa EO; Lasuba CLP; Alemu W; Okogbenin S; Ogbaini E; Unigwe U; Ogah E; Onoh R; Abejegah C; Ayodeji O; Ihekweazu C
    Emerg Infect Dis; 2019 May; 25(5):1026-1027. PubMed ID: 30807268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.
    Yaro CA; Kogi E; Opara KN; Batiha GE; Baty RS; Albrakati A; Altalbawy FMA; Etuh IU; Oni JP
    BMC Infect Dis; 2021 Feb; 21(1):149. PubMed ID: 33546623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the emergency phase for response against endemic disease outbreak: A case of Lassa fever outbreak in Nigeria.
    Ipadeola O; Furuse Y; de Gooyer T; Dan-Nwafor C; Namara G; Ilori E; Ihekweazu C
    J Glob Health; 2020 Dec; 10(2):020353. PubMed ID: 33110549
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential for Seasonal Lassa Fever Case Exportation from Nigeria.
    Tuite AR; Watts AG; Kraemer MUG; Khan K; Bogoch II
    Am J Trop Med Hyg; 2019 Mar; 100(3):647-651. PubMed ID: 30693858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Lassa Fever and Factors Associated with Deaths, Bauchi State, Nigeria, 2015-2018.
    Abdulkarim MA; Babale SM; Umeokonkwo CD; Bamgboye EA; Bashorun AT; Usman AA; Balogun MS
    Emerg Infect Dis; 2020 Apr; 26(4):799-801. PubMed ID: 32186504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and Lassa fever in Nigeria: A deadly alliance?
    Musa SS; Zhao S; Abdullahi ZU; Habib AG; He D
    Int J Infect Dis; 2022 Apr; 117():45-47. PubMed ID: 35108609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of Lassa fever and use of infection prevention and control facilities among health care workers during Lassa fever outbreak in Ondo State, Nigeria.
    Ijarotimi IT; Ilesanmi OS; Aderinwale A; Abiodun-Adewusi O; Okon IM
    Pan Afr Med J; 2018; 30():56. PubMed ID: 30197747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic modelling of the large-scale Lassa fever epidemics in Nigeria from 2016 to 2019.
    Musa SS; Zhao S; Gao D; Lin Q; Chowell G; He D
    J Theor Biol; 2020 May; 493():110209. PubMed ID: 32097608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
    Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
    PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.